Higher fatty acid triester compound having...

Details Higher fatty acid triester compound having... Higher fatty acid triester compound having...

2011-01-18

2011-01-18

Carr, Deborah D (Department: 1621)

Drug, bio-affecting and body treating compositions

In vivo diagnosis or in vivo testing

C424S450000, C534S016000

Reexamination Certificate

active

07871596

ABSTRACT:
A compound having superior solubility and suitable for a liposome contrast medium selective for a lesion such as vascular diseases is provided which is represented by the following general formula (I)wherein R1, R2and R3independently represent an alkyl group or an alkenyl group having 8 to 25 carbon atoms; X represents —O—, or —N(Z)— (Z represents hydrogen atom, or an alkyl group having 1 to 3 carbon atoms); and L represents a divalent bridging group constituted by atoms selected from the group consisting of carbon atom, hydrogen atom, oxygen atom, nitrogen atom and sulfur atom; Ch represents a functional group represented by the following general formula (II), and in the general formula (II), any one of the hydrogen atom Ha, Hb, Hc, Hd, He, and Hfis substituted with L.

REFERENCES:
patent: 2008-150318 (2008-07-01), None
patent: 97/26921 (1997-07-01), None
patent: 2007/072983 (2007-06-01), None
Database WPI Week 200750, Thomson Scientific, London, GB; AN 2007-509658. XP002497621.
Extended European Search Report dated Oct. 7, 2008.

Affiliated with

Also associated with

Rating

Higher fatty acid triester compound having... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Higher fatty acid triester compound having..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Higher fatty acid triester compound having... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2671110